That selectivity is the reason Ipamorelin became the default GHRP for research planning
There are no legitimate long-term data to support it
Both nutrient ingredients bolster skin protection against environmental stressors
The correct classification: Pure GLP-1 agonists: exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, efpeglenatide, orforglipron Dual GIP/GLP-1 agonists: tirzepatide Triple agonists (GIP/GLP-1/glucagon): retatrutide Retatrutide, approved in early 2026, adds glucagon receptor agonism to the dual GIP/GLP-1 mechanism
Approval means clean manufacturing, proper dosage, and ingredients safe for daily use, which protects Filipinos from unregulated whitening drips and fake glutathione claims